WST | West Pharmaceutical ServicesNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$406.99
-$0.89 (-0.22%)

West Pharmaceutical Services (WST) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since May 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour. On the weekly a golden cross is projected within 10 bars.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $406.99 vs 50 $369.77 / 200 $314.76
Projection
No cross projected
Test
No active test
Last cross
Golden cross 5 May 2026 ยท projected 26 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $412.62 vs 50 $306.81 / 200 $311.45
Projection
Golden cross projected in 3 bars
Test
No active test
Last cross
Death cross week of 7 Oct 2024 ยท projected 29 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $406.99 vs 50 $385.31 / 200 $359.25
Projection
No cross projected
Test
No active test
Last cross
Golden cross 23 Apr 2026 ยท projected 27 bars out

Cross history

23
crosses on record since 2018
11 golden12 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
5 May 2026Golden steepdaily26 bars outNot tested
23 Apr 2026Golden4-hour27 bars outNot tested
12 Mar 2026Death moderatedaily29 bars outNot tested
27 Jan 2026Death4-hour30 bars outNot tested
1 Oct 2025Golden steepdaily21 bars outNot tested

About WST

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$182M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.